Yi Rong was appointed editor-in-chief of the American Association Of Physicists In Medicine’s Journal of Applied Clinical Medical Physics by the AAPM board of directors.
Shane Jacobson was appointed CEO of the American Cancer Society and the American Cancer Society Cancer Action Network.
The Stephenson Global Pancreatic Cancer Research Institute and its partner, City of Hope, announced the six inaugural recipients of the Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, early detection, and treatment of pancreatic cancer (The Cancer Letter, Sept. 17, 2024).
Dispatch Bio, a company aiming to engineer a universal immunotherapy treatment across solid tumors, announced its official launch.Â
Mary Woolley will step down as president and CEO of Research!America in early 2026. She has led the non-profit medical and health research advocacy alliance for 35 years.
A $100 million matching grant from the Weill Family Foundation is supporting the launch of the Weill Cancer Hub West—a collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center and the Stanford Cancer Institute—set up to accelerate discoveries and speed the development of innovative new treatments for patients.Â
From left to right: Christina M. Puchalski, Julie Bauman, Sharad Goyal Sharad Goyal and Christina M. Puchalski received endowed professorships at the George Washington University Cancer Center and School of Medicine and Health Sciences for their academic excellence and leadership in patient care.
Rob Brainin was named CEO of Champions Oncology, a provider of oncology-focused contract research organization services specializing in preclinical and clinical specialty testing. He has been a member of the Champions’ board of directors since 2021.
Geraldine O’Sullivan Coyne was appointed system head of Northwell and principal investigator for the START Center for Cancer Research, a newly established unit at the health system aimed at bringing innovative early stage clinical trials to patients in a community-based cancer center.
The Society for Immunotherapy of Cancer Forward Fund announced the recipients of the 2025 SITC Fellowships.
